Normal view MARC view ISBD view

Substituted phthalocyanines as photodynamic sensitizers. [electronic resource]

By:

Rosenthal, I

Contributor(s):

Producer: 19890623Description: 467-72 p. digitalISSN:

0090-5542

Subject(s):

Online resources:

Available from publisher's website

In: Basic life sciences vol. 49

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

81 Visfatin, a new adipocytokine, is predominantly related to inflammation/endothelial damage in kidney allograft recipients.
by Malyszko, J
82 Construction, expression and preliminary characterization of glycosylation mutants of human protein S.
by Rydzewski, A
83 Tissue factor pathway inhibitor and tissue factor in HD and CAPD.
by Małyszko, J
84 Markers of endothelial cell injury and thrombin activatable fibrinolysis inhibitor in nephrotic syndrome.
by Malyszko, J
85 Fungaemia due to Cryptococcus laurentii as a complication of immunosuppressive therapy--a case report.
by Furman-Kuklińska, K
86 Prostacyclin and atherosclerosis in rats.
by Villa, S
87 Fibrinolysis and tourniquet: Evidence from rats.
by Mysliwiec, M
88 [Fibrinolytic and lipid disturbances in patients with nephrotic syndrome].
by Małyszko, J
89 Tissue factor and tissue factor pathway inhibitor in acute and chronic renal failure.
by Malyszko, J
90 [Tissue factor and inhibitor of the blood coagulation pathway in nephrotic syndrome].
by Małyszko, J S
91 Effects of mycophenolate mofetil and mycophenolic acid on platelet aggregation in vitro.
by Malyszko, J
92 Comparison of hemostatic disturbances between patients on CAPD and patients on hemodialysis.
by Malyszko, J
93 [Early thrombocytopenia after administration of heparin in patients with chronic renal failure].
by Myśliwiec, M
94 [Effect of heparin and prostacyclin on blood platelet activity].
by Kisiel, S
95 Erythrocyte sedimentation and soluble fibrin monomer complexes.
by Lipiński, B
96 Ketanserin and erythropoiesis in hemodialysis patients with polycystic kidneys.
by Borawski, J
97 [Fibrinolytic and peripheral serotonergic system in patients with glomerulonephritis].
by Małyszko, J
98 Ketanserin lowers erythropoietin concentration in hemodialyzed patients treated with the hormone.
by Borawski, J
99 [Ketanserin decreases erythropoietin concentration in hemodialyzed patients on rHuEPO therapy].
by Borawski, J
100 [Use of low-molecular weight heparin during hemodialysis].
by Kalinowski, M